Religem 1000mg Injection
Marketer
Relic Biotechnology Pvt Ltd
Salt Composition
Gemcitabine (1000mg)
Overview Religem 1000mg Injection
Oncaspar 1000mg Injection treats several cancers including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your specific condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical guidance. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can reduce blood cell counts, increasing infection risk, necessitating regular blood tests to monitor blood cell levels, along with heart, liver, and uric acid levels. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of other medications, especially antibiotics, prior to treatment commencement. Many drug interactions are possible; disclose all medications to your doctor. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Uses of Religem 1000mg Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Religem 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Religem 1000mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Religem 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Religem 1000mg Injection works:
Religem 1000mg Injection inhibits cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential nucleotides. This action effectively halts tumor growth and expansion.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Religem 1000mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Religem 1000mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Religem 1000mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Religem 1000mg Injection might reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving is prohibited should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Religem 1000mg Injection use in individuals with renal impairment is scarce. Physician consultation is necessary. Pre-treatment and post-treatment kidney function assessments are recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Religem 1000mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Religem 1000mg Injection :
NA
Facts to Know About Religem 1000mg Injection
| Label | Value |
|---|---|
| Chemical Category | Cytosine Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Metabolic inhibitors |
3,018 People bought this recently